Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Other Operating Expense : ¥35 Mil (TTM As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co Other Operating Expense?

Shanghai Kaibao Pharmaceutical Co's Other Operating Expense for the three months ended in Jun. 2024 was ¥25 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥35 Mil.

Shanghai Kaibao Pharmaceutical Co's quarterly Other Operating Expense declined from Dec. 2023 (¥22 Mil) to Mar. 2024 (¥5 Mil) but then increased from Mar. 2024 (¥5 Mil) to Jun. 2024 (¥25 Mil).

Shanghai Kaibao Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥37 Mil) to Dec. 2022 (¥40 Mil) but then declined from Dec. 2022 (¥40 Mil) to Dec. 2023 (¥35 Mil).

Shanghai Kaibao Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kaibao Pharmaceutical Co Other Operating Expense Chart

Shanghai Kaibao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

48.27

27.58

37.45

40.39

35.26

Shanghai Kaibao Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Operating Expense	Get a 7-Day Free Trial															25.08	-16.95	21.59	5.48	24.90

Shanghai Kaibao Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥35 Mil.

Shanghai Kaibao Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kaibao Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401

Website

http://www.xykb.com

Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.

Executives

Liu Shao Yong	Supervisors
Ren Li Wang	Secretary Dong
Zhang Tao	Executives
Mu Jing Wei	Director
Li Xiu Hai	Directors, executives
Zhang Lian Xin	Supervisors
Han Jing	Independent director
Wang Guo Ming	Directors, executives
Wang Chong Bang	Executives
Liu Yi Shan	Director
Li Qing Wei	Independent director
Mu Lai An	Director
Zhu Ying Jun	Executives
Chang Qing Ling	Supervisors
Zhang Peng	Director

Shanghai Kaibao Pharmaceutical Co Headlines

No Headlines